What is going on with these SON stocks. SONN not SONM up
premarket after a large drop recently. Now .72 cents premarket up
from .56 cents.
BTIG initiates coverage on Sonnet
BioTherapeutics (NASDAQ:
SONN)
with a Buy rating and announces Price Target of $5.
SUNM down to .38 cents premarket from .70s cent on
Friday.
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
What is going on with
Posted by EdZ on 15th of Sep 2021 at 09:20 am
What is going on with these SON stocks. SONN not SONM up premarket after a large drop recently. Now .72 cents premarket up from .56 cents. BTIG initiates coverage on Sonnet BioTherapeutics (NASDAQ: SONN) with a Buy rating and announces Price Target of $5. SUNM down to .38 cents premarket from .70s cent on Friday.